Cargando…
Antithrombotic therapy and survival in patients with malignant disease
A broad range of studies suggest a two-way relationship between cancer and venous thromboembolism (VTE). Patients with cancer have consistently been shown to be at elevated risk for VTE; this risk is partly driven by an intrinsic hypercoagulable state elicited by the tumour itself. Conversely, throm...
Autores principales: | Kakkar, A K, Macbeth, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315364/ https://www.ncbi.nlm.nih.gov/pubmed/20386547 http://dx.doi.org/10.1038/sj.bjc.6605602 |
Ejemplares similares
-
Antithrombotic Therapies in COVID-19 Disease: a Systematic Review
por: Maldonado, Edward, et al.
Publicado: (2020) -
Does antithrombotic therapy improve survival with colorectal cancer?
por: Takahashi, Kodai, et al.
Publicado: (2017) -
Antithrombotic therapy in peripheral arterial disease
por: Espinola-Klein, Christine, et al.
Publicado: (2022) -
The impact of antithrombotic therapy on the time of detection of bladder cancer
por: Jakus, Dora, et al.
Publicado: (2022) -
Antithrombotic therapy in TAVI
por: Vavuranakis, Manolis, et al.
Publicado: (2018)